e.g., HRA000087; HRA000150
HRA004529
Title:
The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
Release date:
2023-05-08
Description:
Diagnosis classification and risk stratification are of crucial in the survival prognostication and treatment selection of acute myeloid leukemia (AML). Here, we used a database of 536 AML patients to compare the 4th and 5th WHO, as well as the 2017 and 2022 version of ELN guidance.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
acute myeloid leukemia
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC
Contact person:
he pengcheng
Email:
hepc@163.com
Description:
Diagnosis classification and risk stratification are of crucial in the survival prognostication and treatment selection of acute myeloid leukemia (AML). Here, we used a database of 536 AML patients to compare the 4th and 5th WHO, as well as the 2017 and 2022 version of ELN guidance.
Individuals & samples
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
HRI612986bone marrow1femaleHRS812459bone marrow1Patient blood samples
HRI612987bone marrow2maleHRS812460bone marrow2Patient blood samples
HRI612988bone marrow3femaleHRS812461bone marrow3Patient blood samples
HRI612989bone marrow4femaleHRS812462bone marrow4Patient blood samples
HRI612990bone marrow5femaleHRS812463bone marrow5Patient blood samples
HRI612991bone marrow6maleHRS812464bone marrow6Patient blood samples
HRI612992bone marrow7maleHRS812465bone marrow7Patient blood samples
HRI612993bone marrow8maleHRS812466bone marrow8Patient blood samples
HRI612994bone marrow9maleHRS812467bone marrow9Patient blood samples
HRI612995bone marrow10maleHRS812468bone marrow10Patient blood samples
Showing 1 to 10 of 101 rows rows per page
Run accession
Files
Experiment
Experiment title
Platform
Sample
Run accession
Files
Experiment
Experiment title
Platform
Sample
HRR1183226HRR1183226_f1.fastq.gz (0.05 GB)HRX929668Next generation sequencing1Illumina Genome Analyzer IIHRS812459 (SAMC2767030)
HRR1183226HRR1183226_r2.fastq.gz (0.05 GB)HRX929668Next generation sequencing1Illumina Genome Analyzer IIHRS812459 (SAMC2767030)
HRR1183227HRR1183227_f1.fastq.gz (0.08 GB)HRX929669Next generation sequencing2Illumina Genome Analyzer IIHRS812460 (SAMC2767034)
HRR1183227HRR1183227_r2.fastq.gz (0.09 GB)HRX929669Next generation sequencing2Illumina Genome Analyzer IIHRS812460 (SAMC2767034)
HRR1183228HRR1183228_f1.fastq.gz (0.12 GB)HRX929670Next generation sequencing3Illumina Genome Analyzer IIHRS812461 (SAMC2767037)
HRR1183228HRR1183228_r2.fastq.gz (0.12 GB)HRX929670Next generation sequencing3Illumina Genome Analyzer IIHRS812461 (SAMC2767037)
HRR1183229HRR1183229_f1.fastq.gz (0.08 GB)HRX929671Next generation sequencing4Illumina Genome Analyzer IIHRS812462 (SAMC2767041)
HRR1183229HRR1183229_r2.fastq.gz (0.09 GB)HRX929671Next generation sequencing4Illumina Genome Analyzer IIHRS812462 (SAMC2767041)
HRR1183230HRR1183230_f1.fastq.gz (0.10 GB)HRX929672Next generation sequencing5Illumina Genome Analyzer IIHRS812463 (SAMC2767045)
HRR1183230HRR1183230_r2.fastq.gz (0.10 GB)HRX929672Next generation sequencing5Illumina Genome Analyzer IIHRS812463 (SAMC2767045)
Showing 1 to 10 of 202 rows rows per page
Submitter:   he pengcheng / hepc@163.com
Organization:   The First Affiliated Hospital of Xi'an Jiaotong University
Submission date:   2023-05-04
Requests:   -